ACTA NEUROPHARMACOLOGICA››2020,Vol. 10››Issue (4): 36-40.DOI:10.3969/j.issn.2095-1396.2020.04.007
Previous ArticlesNext Articles
LIU Chang,MENG Xian-yong,DONG Xiao-hua
Online:
2020-08-26Published:
2020-08-26Contact:
董晓华,女,硕士生导师;研究方向:神经精神药理学;E-mail:hbdxh76@163.comSupported by:
CLC Number:
LIU Chang, MENG Xian-yong, DONG Xiao-hua. Research Progress on Pathogenesis and Therapeutic Drugs of Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 36-40.
[1] Bai Bing, Chadwick M Hales, Ping-Chung Chen.U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease[J]. Proceedings of the National Academy of Sciences of the United States of America, 2015, 110(41): 16562-16566. [2] Sandrine Andrieu, Sophie Gillette, Karine Amouyal,et al.Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study[J]. J Gerontology Series A: Biological Sciences and Medical Sciences, 2014, 8(4): 55-61. [3] 宋昕, 洪羽蓉, 胡秋莹. 阿尔茨海默症发病原因及机制的研究进展[J]. 临床和实验医学杂志, 2015, (10):91-93. [4] 左萍萍. β淀粉样肽代谢与阿尔茨海默症[J]. 标记免疫分析与临床, 2001, 8(1):34-37. [5] 干伟. RNA氧化在阿尔茨海默症发病中的作用机制研究[D]. 北京:北京协和医学院, 2013: 23-31. [6] 王金春, 刘慧影, 曹云鹏. tau蛋白与阿尔茨海默症[J]. 中国组织工程研究, 2014, 6(17): 66-75. [7] Piotr Lewczuk, Hermann Esselmann, Mirko Bibl,et al.Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease[J]. J Molecular Neuroscience, 2004, 23(1-2): 115-122. [8] Tian J, Shi Jing-ying, Mann D M.Cerebral amyloid angiopathy and dementia[J]. Brain, 2004, 8(2): 87-91. [9] 胡钰慧, 何玲. 线粒体功能障碍与阿尔茨海默症发病的相关性研究进展[J]. 药学研究, 2020, (2): 101-104. [10] Dennis J Selkoe.Toward a comprehensive theory for Alzheimer's disease-Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein[J]. Conference on Towards A Comprehensive Theory for Alzheimers Diaease, 2017, 7(5): 43-49. [11] 王威丽, 宋沧桑. 阿尔茨海默症发病机制的研究进展及临床用药[J]. 中国药物评价, 2019, 6(3): 204-209. [12] Jon Toledo, Henrik Zetterberg, Argonde C Van Harten,et al.Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects[J]. Brain, 2009, 7(9): 88-94. [13] Wang Peng-cheng, Wang Qiu-hong, Yang Bing-you,et al.The progress of metabolomics study in traditional chinese medicine research[J]. American J Chinese Medicine, 2015, 8(4): 28-30. [14] 常艳, 薛毅珑. 阿尔茨海默症的发病机制及其研究进展[J]. 中国组织工程研究, 2016, 8(4): 693-695. [15] 刘佳福, 刘振国. 阿尔茨海默症炎症发病机制的研究进展[J]. 中风与神经疾病杂志, 2004, 21(5): 471-472. [16] Fan Wu-qiang, Toshihiko Yanase, Hidetaka Morinaga,et al.Atrazine-induced aromatase expression is SF-1 dependent: implications for endocrine disruption in wildlife and reproductive cancers in humans[J]. Environmental Health Perspectives, 2017, 115(5):720-727. [17] 顾亦婷, 顾海. 阿兹海默症中西医辨证治疗[J]. 辽宁中医药大学学报, 2015, 12(8): 139-141. [18] 苗霞. 以Tau蛋白为靶标治疗阿尔茨海默症的分子设计[D]. 重庆:重庆大学, 2012:31-35. [19] Gao Yong-lei, Wang Nan, Sun Fu-rong,et al.Tau in neurodegenerative disease[J]. Annals of Translational Medicine, 2018, 6(10): 175-175. [20] Claude Michel Wischik, Novak M, Thogersen H C,et al.Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease[J]. Proceedings of the National Academy of Sciences, 1988, 85(12): 4506-4510. [21] 周妍妍, 杨光, 康倩倩, 等. 单味中药及有效成分对阿尔茨海默症Aβ沉积影响的实验研究进展[J]. 中国中医药现代远程教育, 2019, 17(03):127-129. [22] Holmes C, Cunningham C, Zotova E,et al.Proinflammatory cytokines, sickness behavior, and Alzheimer disease[J]. Neurology, 2011, 77(3): 212-218. [23] 白淑玉. 中医对阿兹海默病的认识与辨证论治[J]. 中国医药指南, 2007, 2(S1): 45-49. [24] Marcela Colombres, Juan Paulo Sagal, Nibaldo C Inestrosa.An overview of the current and novel drugs for Alzheimer's disease with particular reference to anti-cholinesterase compounds[J]. Current Pharmaceutical Design, 2018, 10(25): 3121-3130. [25] 张春燕, 杨斌, 舒雨雁, 等. 神经生长因子偶联物对老年性痴呆动物模型的保护作用[J]. 中华生物医学工程杂志, 2004, 10(2): 85-87, 90. [26] Kirk P Townsend, Domenico Pratico.Novel therapeutic opportunities for Alzheimer’s disease: focus on nonsteroidal anti-inflammatory drugs[J]. J Faseb, 2015, 19(12): 1592-1601. [27] Tortosa E, Avila J, M Pérez.Acetylsalicylic acid decreases tau phosphorylation at serine 422[J]. Neuroence Letters, 2016, 396(1): 77-80. [28] 朱榆红, 冯忠堂. 老年性痴呆的基因治疗与神经生长因子[J]. 中华医学研究杂志, 2015, 7(6): 34-39. [29] 冯晓灵. 老年痴呆的病因及药物治疗现状[J]. 医学理论与实践, 2016, 29(4): 444-445,448. [30] 付新, 常玉新, 张洋, 等. 中药治疗老年痴呆症的研究综述[J]. 中医药学报, 2016, 8(4): 130-132. [31] 李斌, 伍文彬, 谢淑玲, 等. 黄连解毒汤对2型糖尿病大鼠学习记忆能力及脑内Alzheimer病样tau蛋白磷酸化途径的影响[J].中华中医药杂志, 2015, 30(5):1421-1425. [32] 余世敏. 涤痰汤对Alzheimer病模型大鼠行为学及中枢胆碱能系统的影响[D].武汉:湖北中医学院, 2007: 60-65. [33] 宋建芳, 王宏洁, 司南, 等. 黄连解毒汤的抗氧化作用及抑制乙酰胆碱酯酶活性的研究[J]. 中国实验方剂学杂志, 2010, 16(5): 61-64. [34] 程海英, 程东旗. 针灸治疗老年性痴呆相关评价指标的研究进展[J]. 中国针灸, 2016, 26(8): 605-608. [35] 周妍妍, 姚辛敏, 何秀丽, 等. 地黄饮子对Aβ诱导的PC12细胞SODmRNA表达影响的研究[J]. 中西医结合心脑血管病杂志, 2018, 9(6): 704-706. [36] 郎俊. 温脾通络开窍汤辨证加减治疗老年性痴呆痰浊阻窍证临床研究[J]. 四川中医, 2015, 7(7): 83-85. [37] Goode B L, Denis P E, Panda D,et al. Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly[J]. Molecular Biology of the Cell, 1997, 8(2): 353-365. [38] Yan Jing-lai, Chen Yan-qing.Traditional Chinese medical understanding on pathogenesis of senile dementia[J]. China J Traditional Chinese Medicine and Pharmacy, 2018, 23(7): 640-642. |
[1] | Tang Min-ke,Fan Yue,Liu Chang-suo,Zhang Jun-tian.Progress of The Mechanisms of Neuroprotective Effects of Salvianolic Acid B[J]. Acta Neuropharmacologica, 2014, 4(1): 1-10. |
[2] | LI Li-xuan, LI Xiao-hui.The Mechanisms and Research Progress of Tau Abnormality Leading to AD Related Neurodegenerative Taupathies[J]. ACTA NEUROPHARMACOLOGICA, 2011, 1(5): 34-39. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||